Authors: Feldman, H Gauthier, S Hecker, J Vellas, B Subbiah, P Whalen, E

Citation: H. Feldman et al., A 24-week, randomized, double-blind study of donepezil in moderate to severe Alzheimer's disease, NEUROLOGY, 57(4), 2001, pp. 613-620

Authors: Winblad, B Engedal, K Soininen, H Verhey, F Waldemar, G Wimo, A Wetterholm, AL Zhang, R Haglund, A Subbiah, P

Citation: B. Winblad et al., A 1-year, randomized, placebo-controlled study of donepezil in patients with mild to moderate AD, NEUROLOGY, 57(3), 2001, pp. 489-495

Authors: Feldman, H Gauthier, S Hecker, J Vellas, B Subbiah, P Whalen, E

Citation: H. Feldman et al., A 24-week, randomized, double-blind study of donepezil in moderate to severe Alzheimer's disease (vol 57, pg 613, 2001), NEUROLOGY, 57(11), 2001, pp. 2153-2153

Authors: Waldemar, G Winblad, B Engedal, K Soininen, H Verhey, F Wimo, A Wetterholm, AL Zhang, R Haglund, A Subbiah, P

Citation: G. Waldemar et al., Benefits of donepezil on cognition, function and neuropsychiatric symptomsin patients with mild and moderate Alzheimer's disease over one year, ALZHEIMER'S DISEASE, 2001, pp. 725-738